Marker Therapeutics Ownership | Who Owns Marker Therapeutics?
Marker Therapeutics Ownership Summary
Marker Therapeutics is owned by 11.43% institutional investors, 5.49% insiders, and 83.08% retail investors. Nea management company is the largest institutional shareholder, holding 11.65% of MRKR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.57% of its assets in Marker Therapeutics shares.
MRKR Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Marker Therapeutics | 11.43% | 5.49% | 83.08% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Nea management company | 1.63M | 11.65% | $1.45M |
| Blue owl capital lp | 554.25K | 3.31% | $825.83K |
| Vanguard group | 346.07K | 2.07% | $515.65K |
| Aisling capital management lp | 325.37K | 1.94% | $484.80K |
| Ubs group | 174.03K | 1.04% | $259.30K |
| Geode capital management | 130.34K | 0.78% | $194.24K |
| Renaissance | 123.65K | 0.74% | $184.24K |
| Advisor group | 81.08K | 0.58% | $74.23K |
| Lpl financial | 83.25K | 0.50% | $124.04K |
| Two sigma securities | 47.60K | 0.34% | $42.49K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aisling capital management lp | 325.37K | 0.10% | $484.80K |
| Nea management company | 1.63M | 0.08% | $1.45M |
| Blue owl capital lp | 554.25K | 0.06% | $825.83K |
| Two sigma securities | 47.60K | 0.01% | $42.49K |
| Invst | 27.00K | 0.00% | $40.23K |
| Matrix asset advisors inc/ny | 15.00K | 0.00% | $22.35K |
| Virtu financial | 28.33K | 0.00% | $25.00K |
| Xtx topco | 21.77K | 0.00% | $19.43K |
| Ashton thomas private wealth | 10.00K | 0.00% | $14.90K |
| Renaissance | 123.65K | 0.00% | $184.24K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 174.03K | - | 168.23K |
| Advisor group | 81.08K | 0.00% | 61.50K |
| Two sigma securities | 47.60K | 0.01% | 47.60K |
| Vanguard group | 346.07K | - | 46.29K |
| Jane street group | 40.52K | - | 40.52K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Hudson bay capital management lp | - | - | -499.73K |
| Alyeska investment group | - | - | -213.02K |
| Ar asset management | - | - | -73.70K |
| Squarepoint ops | - | - | -43.30K |
| Dimensional fund advisors lp | - | - | -15.90K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma securities | 47.60K | 0.01% | 47.60K | $42.49K |
| Two sigma investments, lp | 36.54K | - | 36.54K | $32.62K |
| Virtu financial | 28.33K | 0.00% | 28.33K | $25.00K |
| Xtx topco | 21.77K | 0.00% | 21.77K | $19.43K |
| Hrt financial lp | 13.94K | 0.00% | 13.94K | $20.00K |
Sold Out
| Holder | Change |
|---|---|
| Versant capital management | -15.00 |
| Riggs asset managment | -1.20K |
| Tower research capital llc (trc) | -3.38K |
| Raymond james financial | -9.52K |
| Dimensional fund advisors lp | -15.90K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 26 | -18.75% | 1,915,186 | -44.57% | 11 | 1.86% | 11 | -35.29% | 3 | - |
| Sep 30, 2025 | 31 | - | 3,426,371 | 0.47% | 24 | 2.60% | 16 | 45.45% | 3 | -50.00% |
| Jun 30, 2025 | 30 | -3.23% | 3,379,937 | -17.03% | 30 | 2.26% | 9 | -25.00% | 7 | 16.67% |
| Mar 31, 2025 | 1 | - | 73,700 | - | - | 97.29% | - | - | - | - |
| Dec 31, 2024 | 1 | - | 73,700 | - | - | 121.08% | - | -100.00% | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 261.24K | 1.57% | 79.52K |
| Vanguard US Total Market Shares ETF | 153.47K | 1.43% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 95.82K | 0.57% | 7.55K |
| Fidelity Extended Market Index | 76.34K | 0.46% | 29.55K |
| WEALTHGATE Biotech Aggressive Fund I | 25.44K | 0.29% | - |
| Vifag 2002 SICAV | 30.00K | 0.23% | - |
| DFA US Small Cap I | 15.90K | 0.14% | - |
| NT Ext Equity Mkt Idx Fd - L | 19.90K | 0.12% | 15.15K |
| iShares Micro-Cap ETF | 12.60K | 0.11% | - |
| WEALTHGATE Biotech Fund Inst | 9.51K | 0.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 23, 2024 | ELMS STEVE | - | Buy | $35.47K |
| Dec 23, 2024 | New Enterprise Associates 16, L.P. | - | Buy | $1.77M |
| Mar 16, 2021 | Eansor Norman David | - | Buy | $249.99K |
| May 18, 2021 | Wasserman Frederick Gerald | - | Buy | $24.10K |
| Mar 16, 2021 | Walker Paul Edward | - | Buy | $10.00M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | 2 | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
MRKR Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools